Influência da administração de eritropoietina humana recombinante sobre o desempenho físico: estudo de revisão.

• Autores: P.C. Caetano Júnior, T.S. Cunha, L.C. Lemes, S.R. Ribeiro, Welington Ribeiro
• Localización: Revista andaluza de medicina del deporte, ISSN 1888-7546, Vol. 7, Nº. 4, 2014, págs. 170-177
• Idioma: portugués
• DOI: 10.1016/j.ramd.2014.03.001
• Enlaces
  • Texto completo
• Referencias bibliográficas
  • Jacobs K, Shoemaker C, Rudersdorf R, Neill SD, Kaufman RJ, Mufson A, et al. Isola-tion and characterization of genomic and cDNA clones of...
  • Choi D, Kim M, Park J. Erythropoietin: Physico and biochemical analysis. J Chro-matogr B. 1996;687: 189-99.
  • Tanaka T, Nangaku M. Recent advances and clinical application of erythropoietinand erythropoiesis-stimulating agents. Exp Cell Res. 2012;318:...
  • Balestra C, Germonpré P. EPO and doping. Eur J Appl Physiol. 2010;109: 1001-2.
  • Gareau R, Brisson GR, Chénard C, Gagnon MG, Audran M. Total fibrin and fibrino-gen degradation products in urine: A possible probe to detect...
  • River L, Saugy M. Peptides hormones abuse in sport: State of the art in thedetection of growth hormone and erythropoietin. Toxin Rev. 1999;18:...
  • Audran M, Gareau R, Matecki S, Durand F, Chenard C, Sicart MT, et al. Effects oferythropoietin administration in training athletes and possible...
  • Ekblom B, Berglund B. Effect of erythropoietin administration on maximal aero-bic power in man. Scand J Med Sci Sports. 1991;2: 88-93.
  • Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Hug E, Bahr R. Effectof rhEPO administration on serum levels of sTfR and cycling...
  • Lavoie C, Diguet A, Milot M, Gareau R. Erythropoietin (rHuEPO) doping: Effectsof exercise on anaerobic metabolism in rats. Int J Sports Med....
  • Connes P, Caillaud C, Mercier J, Bouix D, Casties JF. Injections of recombinanthuman erythropoietin increases lactate influx into erythrocytes....
  • Meierhenrich R, Jedicke H, Voigt A, Lange H. The effect of erythropoietin onlactate, pyruvate and excess lactate under physical exercise in...
  • Lundby C, Hellsten Y, Jensen MB, Munch AS, Pilegaard H. Erythropoietin recep-tor in human skeletal muscle and the effects of acute and long-term...
  • Lappin T. The cellular biology of erythropoietin receptors. Oncologist.2003;8: 15-8.
  • Acs G, Xu X, Chu C, Acs P, Verma A. Prognostic significance of erythropoietinexpression in human endometrial carcinoma. Cancer. 2004;100:...
  • Schuler B, Vogel J, Grenacher B, Jacobs RA, Arras M, Gassmann M. Acute andchronic elevation of erythropoietin in the brain improves exercise...
  • Adamson JW. Regulation of red blood cell production. Am J Med. 1996;101: 4-6.
  • Aquino Neto FR. O papel do atleta na sociedade e o controle de dopagem noesporte. Rev Bras Med Esporte. 2001;7: 1-11.
  • Berardi D, Agati L. Cardiovascular adverse reactions after the administrationof recombinant human erythropoietin: Light and shade. Minerva...
  • Garcia JMJ, Sánchez ET, Hidalgo DO, Conejo EA. Erytropoietin pharmacology. ClinTransl Oncol. 2007;9: 715-22.
  • Lohmeyer JA, Essmann E, Richerson SJ, Hagel C, Egana JT, Condurache A, et al.Use of erythropoietin as adjuvant therapy in nerve reconstruction....
  • Schmidt CA, Ramos AS, Silva JEP, Fronza M, Dalmora SL. Avaliação da atividadee caracterização de eritropoietina humana recombinante em produtos...
  • Bento RMA, Damasceno LMP, Neto FRA. Eritropoetina humana recombinante noesporte: uma revisão. Rev Bras Med Esporte. 2003;9(3): 169-80.
  • Bahlmann FH, Fliser D. Erythropoietin and renoprotection. Hypertension.2009;18: 15-20.
  • Engert A. Recombinant human erythropoietin in oncology: Current statuts andfurther developments. Ann Oncol. 2005;16: 1584-95.
  • Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP, Dewhirst MW. Erythro-poietin biology in cancer. Clin Cancer Res. 2006;12(2): 332-9.
  • Hsieh MM, Linde NS, Wynter A, Metzger M, Wong C, Langsetmo I, et al. HIFprolyl hydroxylase inhibition results in endogenous erythropoietin...
  • Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietinproduction in human hepatoma cultures and in isolated perfused...
  • Tentori L, Graziani G. Doping with growth hormone/IGF-1, anabolic steroids orerythropoietin: Is there a cancer risk? Pharmacol Res. 2007;55:...
  • Ng T, Marx G, Littlewood T, Macdougall I. Recombinant erythropoietin in clinicalpractice. Postgrad Med J. 2003;79: 367-76.
  • Robach P, Schmitt EL, Brugniaux JV, Nicolet G, Duvallet A, Fouillot JP, et al. Livinghigh-training low: Effect on erythropoiesis and maximal...
  • Tsitsimpikou C, Kouretas D, Tsarouhas K, Fitch K, Spandidos DA, TsatsakisA. Applications and biomonitoring issues of recombinant erythropoietins...
  • Jelkmann W. Erythropoietin: Structure, control of production and function. Phy-siol Rev. 1992;72: 449-89.
  • Inoue N, Takeuchi M, Ohashi H, Suzuki T. The production of recombinant humanerythropoietin. Biotechnol Annu Rev. 1995;1: 297-313.
  • Skibeli V, Nielsen-Lie G, Torjesen P. Sugar profiling proves that humanserum erythropoietin differs from recombinant human erythropoietin....
  • Storring PL, Tiplady RJ, Gaines Das RE, Stenning BE, Lamikanra A, Rafferty B, et al. Epoetin alfa and beta differ in their erythropoietin...
  • Macdougall IC. Meeting the challenges of a new millennium: Optimizing theuse of recombinant human erythropoietin. Nephrol Dial Transplant....
  • Christensen B, Sackmann-Sala L, Cruz-Topete D, Jorgensen JO, Jessen N, LundbyC, et al. Novel serum biomarkers for erythropoietin use in humans:...
  • Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, et al. Discrimi-nation of recombinant and endogenous urinary erythropoietin...
  • Abellan R, Ventura R, Pichini S, Palmi I, Bellver M, Olive R, et al. Effect of physicalfitness and endurance exercise on indirect biomarkers...
  • Robinson N, Giraud S, Saudan C, Baume N, Avois L, Mangin P, et al. Erythropoietinand blood doping. Br J Sports Med. 2006;40: 30-4.
  • Lundby C, Achman-Andersen NJ, Thomsen JJ, Norgaard AM, Robach P. Testing forrecombinant human erythropoietin in urine: Problems associated...
  • Lamon S, Robinson N, Saugy M. Procedures for monitoring recombinant eryth-ropoietin and analogs in doping. Endocrinol Metab Clin N Am. 2010;39:...
  • Tsivou M, Georgakopoulos DG, Dimopoulou HA, Koupparis MA, Atta-Politou J, Georgakopoulos CG. Stabilization of human urine abuse in sports:...
  • John MJ, Jaison V, Jain K, Kakkar N, Jacob JJ. Erythropoietin use and abuse. IndianJ Endocrinol Metab. 2012;16: 220-7.
  • Robach P, Recalcati S, Girelli D, Gelfi C, Aachmann-Andersen NJ, Thomsen JJ.Alterations of systemic and muscle iron metabolism in human subjects...
  • Ashenden M, Clare E, Gough CE, Garnham A, Gore CJ, Sharpe K. Current mar-kers of the Athlete Blood Passport do not flag microdose EPO doping....
  • Lundby C, Robach P. Assessment of total haemoglobin mass: Can itdetect erythropoietin-induced blood manipulations? Eur J Appl Physiol.2010;108:...
  • Ninot G, Connes F, Caillaud C. Effects of recombinant human erythropoietininjections on physical self in endurance athletes. J Sports Sci....
  • Verbrugge DJ, Goodnough LT. The effect of recombinant human erythropoietintreatment on the endurance performance of Sprague-Dawley rats. Scand...
  • Kiss MAPDM, Böhme MTS, Mansoldo AC, Degaki E, Regazzini M. Desempenho etalento esportivos. Rev Paul Educ Fís. 2004;18: 89-100.
  • Jelkmann W, Lundby C. Blood doping and its detection. Blood.2011;118(9): 2395-404.
  • Russell G, Gore CJ, Ashenden MJ, Parisotto R, Hahn AG. Effects of prolonged lowdoses of recombinant human erythropoietin during submaximal...
  • Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, et al.Does recombinant human Epo increase exercise capacity by means other...
  • Thomsen JJ, Rentsch RL, Robach P, Calbet JAL, Boushel R, Rasmussen P, et al.Prolonged administration of recombinant human erythropoietin increases...
  • Wilkerson DP, Rittweger J, Berger NJ, Naish PF, Jones AM. Influence of recombi-nant human erythropoietin treatment on pulmonary O2 uptake...
  • Durussel J, Daskalaki E, Anderson M, Chatterji T, Wondimu DH, Padma-nabhan N, et al. Haemoglobin mass and running time trial performance afterrecombinant...
  • Zagatto AM, Papoti M, Caputo F, Mendes OC, Denadai BS, Baldissera V, et al.Comparação entre a utilização de saliva e sangue para determinação...
  • Freitas JS, Junior MAC, Franco FSC, Rezende LS, Santos AS, Maia HO, et al. Trei-namento aeróbio em natação melhora a resposta de parâmetros...
  • Cayla JL, Maire P, Duvallet A, Wahrmann JP. Erythropoietin induces a shiftof muscle phenotype from fast glycolytic to slow oxidative. Int...
  • Rasmussen P, Foged EM, Krogh-Madsen R, Nielsen J, Nielsen TR, Olsen NV, et al.Effects of erythropoietin administration on cerebral metabolism...
  • Katz O, Stuible M, Golishevski N, Lifshitz L, Tremblay ML, Gassmann M, et al.Erythropoietin treatment leads to reduced blood glucose levels...
  • Mikolás E, Cseh J, PAP M, Szijarto IA, Balogh A, Laczy B, et al. Effects of erythro-poietin on glucose metabolism. HormMetab Res. 2012;44:...
  • Christensen B, Vendelbo MH, Krusenstjerna-Hafstrom T, Madsen M, PedersenSB, Jessen N, et al. Erythropoietin administration acutely stimulates...
  • Lin X, Qu S, Hu M, Jiang C. Protective effect of erythropoietin on renal injury indu-ced by acute exhaustive exercise in the rat. Int J Sports...
  • Lodewijkx HF, Brouwer B. Some empirical notes on the epo epidemic in profes-sional cycling. Res Q Exerc Sport. 2011;82: 740-54.
  • Juel C, Thomsen JJ, Rentsch RL, Lundby C. Effects of prolonged recombinanthuman erythropoietin administration on muscle membrane transport...
  • Martinez-Bello VE, Sanchis-Gomar F, Romagnoli M, Derbre F, Gomez-CabreraMC, Vina J. Three weeks of erythropoietin treatment hampers skeletalmuscle...
  • Eagleton HJ, Littlewood TJ. Update on the clinical use and misuse of erythropoi-etin. Curr Hematol Rep. 2003;2: 109-15.
  • Piloto N, Teixeira HM, Teixeira-Lemos E, Parada B, Garrido P, Sereno J, et al.Erythropoietin promotes deleterious cardiovascular effects and...
  • Cunha TS, Cunha NS, Moura MJCS, Marcondes FK. Esteróides anabólicos androgê-nicos e sua relação com a prática desportiva. Braz J Pharm Sci....
  • Jones EH. Recombinant human erythropoietin. Am J Hosp Pharm. 1989;46: 20-3.
  • Meziri F, Binda D, Touati S, Pellegrin M, Berthelot A, Touyz RM, et al. Exerciseaggravates cardiovascular risks and mortality in rats with...
  • Guglin ME, Koul D. Cardiovascular effects of erythropoietin: anemia and beyond.Cardiol Rev. 2006;14: 200-4.
  • Manolis AS, Tzeis S, Triantafyllou K, Michaelidis J, Pyrros I, Sakellaris N, et al.Erythropoietin in heart failure and other cardiovascular...